ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
0.8066
-0.0431 (-5.07%)
At close: May 16, 2025, 4:00 PM
0.8631
+0.0565 (7.00%)
After-hours: May 16, 2025, 7:59 PM EDT
ProKidney Revenue
ProKidney had revenue of $230.00K in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $306.00K. In the year 2024, ProKidney had annual revenue of $76.00K.
Revenue (ttm)
$306.00K
Revenue Growth
n/a
P/S Ratio
771.55
Revenue / Employee
$1,500
Employees
204
Market Cap
236.09M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
PROK News
- 4 days ago - ProKidney Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 2 months ago - ProKidney Reports Full Year 2024 Financial Results and Business Highlights - GlobeNewsWire
- 2 months ago - Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
- 3 months ago - Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm - PRNewsWire
- 3 months ago - 2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment - Seeking Alpha
- 6 months ago - ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference - GlobeNewsWire
- 6 months ago - ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting - GlobeNewsWire
- 6 months ago - ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference - GlobeNewsWire